share_log

Better Choice Company Inc. (BTTR) Q3 2024 Earnings Call Transcript Summary

Better Choice Company Inc. (BTTR) Q3 2024 Earnings Call Transcript Summary

更好選擇公司(BTTR)2024財年第三季度業績會摘要
富途資訊 ·  11/15 15:53  · 電話會議

The following is a summary of the Better Choice Company Inc. (BTTR) Q3 2024 Earnings Call Transcript:

以下是Better Choice Company Inc.(BTTR)2024年第3季度業績會議記錄摘要:

Financial Performance:

財務表現:

  • Better Choice Company reported a quarter-over-quarter sales growth of 33% to $11.4 million.

  • Achieved a gross margin of 40%, marking the third consecutive quarter of improvement.

  • Reported the first profitable quarter in years with adjusted EBITDA just north of $200,000.

  • Generated net income of $1.5 million for Q3 and earnings per share of $0.74.

  • Better Choice Company報告季度銷售額同比增長33%,達到1140萬美元。

  • 實現40%的毛利率,標誌着連續第三個季度的改善。

  • 報告了多年來首個盈利季度,調整後的EBITDA略高於20萬美元。

  • 第三季度淨利潤爲150萬美元,每股收益爲0.74美元。

Business Progress:

業務進展:

  • Significant operational discipline and improved S&OP process led to a 48% year-over-year reduction in inventory and an average fill rate of 97%.

  • Experienced substantial year-over-year growth in international markets, particularly in the Asia-Pacific region.

  • Increased focus on digital channels resulted in double-digit growth in new-to-brand and repeat consumers.

  • Announced the acquisition of SRx Health, expected to complete in early Q1 2025, which will enhance operational efficiencies and contribute to sustainable growth.

  • 顯著的運營紀律和改善的S&OP流程導致庫存同比減少48%,平均填充率達到97%。

  • 在國際市場,尤其是亞太地域板塊,經驗了可觀的年度增長。

  • 加大對數字渠道的關注,導致新用戶和復購消費者實現兩位數增長。

  • 宣佈收購SRx Health,預計將在2025年初完成,這將提高運營效率並促進可持續增長。

Opportunities:

機會:

  • The demographic shift in Asia, particularly in China, represents a significant opportunity for expansion in the pet food market.

  • The acquisition of SRx Health positions Better Choice to capitalize on increased operational efficiencies and access expanded markets in specialty healthcare.

  • 亞洲的人口結構變化,特別是在中國,爲寵物食品市場的擴張提供了重要機會。

  • 收購SRx Health將使Better Choice能夠利用提高的運營效率並進入特殊醫療保健領域的擴展市場。

Risks:

風險:

  • No explicit risks mentioned.

  • 未提及明顯風險。

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:如需更全面的詳情,請參閱投資人關係網站。本文僅供投資者參考,不作任何指引或建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論